Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Mepolizumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mepolizumab 100mg powder for solution for injection vials
0304020Y0AAAAAA
|
Mepolizumab | Mepolizumab | Respiratory System | No data available |
|
Mepolizumab 100mg/1ml inj pre-filled disposable devices
0304020Y0AAACAC
|
Mepolizumab | Mepolizumab | Respiratory System | No data available |
|
Mepolizumab 100mg/1ml inj pre-filled syringes
0304020Y0AAABAB
|
Mepolizumab | Mepolizumab | Respiratory System | No data available |
|
Nucala 100mg powder for solution for injection vials
0304020Y0BBAAAA
|
Nucala | Mepolizumab | Respiratory System | No data available |
|
Nucala 100mg/1ml solution for injection pre-filled pens
0304020Y0BBACAC
|
Nucala | Mepolizumab | Respiratory System | No data available |
|
Nucala 100mg/1ml solution for injection pre-filled syringes
0304020Y0BBABAB
|
Nucala | Mepolizumab | Respiratory System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.